CAS 211096-49-0: N-(2-Bromophenyl)-N'-(4-cyano-1H-1,2,3-benzotriazol-7-yl)urea

Description: N-(2-Bromophenyl)-N'-(4-cyano-1H-1,2,3-benzotriazol-7-yl)urea is a chemical compound characterized by its unique structure, which includes a urea moiety linked to a 2-bromophenyl group and a 4-cyano-1H-benzotriazole. This compound typically exhibits properties such as moderate solubility in organic solvents and potential biological activity, making it of interest in pharmaceutical and agrochemical research. The presence of the bromine atom and the cyano group can influence its reactivity and interaction with biological targets. Additionally, the benzotriazole ring is known for its stability and ability to form hydrogen bonds, which may enhance the compound's efficacy in various applications. Its molecular structure suggests potential uses in areas such as drug development, where the unique combination of functional groups can lead to novel therapeutic agents. As with many synthetic compounds, safety and handling precautions should be observed due to potential toxicity or reactivity.

Formula: C₁₄H₉BrN₆O

Synonyms:

• Sb-265610

Urea, N-(2-bromophenyl)-N'-(4-cyano-1H-benzotriazol-7-yl)-

CAS: 211096-49-0

• Formula: C₁₄H₉BrN₆O
• Purity: 98%
• Color and Shape: Solid
• Molecular weight: 357.16486

SB-265610

CAS: 211096-49-0

SB-265610 (GSK-CXCR2) is a nonpeptide and allosteric CXCR2 antagonist.

• Formula: C₁₄H₉BrN₆O
• Purity: 97.67%
• Color and Shape: Solid
• Molecular weight: 357.16

SB-265610

CAS: 211096-49-0

SB-265610 is a selective inhibitor of the EGF receptor, which binds to the epidermal growth …

• Formula: C₁₄H₉BrN₆O
• Purity: Min. 95%
• Molecular weight: 357.16 g/mol